Unknown

Dataset Information

0

CHD4-regulated plasmin activation impacts lymphovenous hemostasis and hepatic vascular integrity.


ABSTRACT: The chromatin-remodeling enzyme CHD4 maintains vascular integrity at mid-gestation; however, it is unknown whether this enzyme contributes to later blood vessel or lymphatic vessel development. Here, we addressed this issue in mice harboring a deletion of Chd4 specifically in cells that express lymphatic vessel endothelial hyaluronan receptor 1 (LYVE1), which include lymphatic endothelial cells (LECs) and liver sinusoidal endothelial cells. Chd4 mutant embryos died before birth and exhibited severe edema, blood-filled lymphatics, and liver hemorrhage. CHD4-deficient embryos developed normal lymphovenous (LV) valves, which regulate the return of lymph to the blood circulation; however, these valves lacked the fibrin-rich thrombi that prevent blood from entering the lymphatic system. Transcripts of the urokinase plasminogen activator receptor (uPAR), which facilitates activation of the fibrin-degrading protease plasmin, were upregulated in Chd4 mutant LYVE1+ cells, and plasmin activity was elevated near the LV valves. Genetic reduction of the uPAR ligand urokinase prevented degradation of fibrin-rich thrombi at the LV valves and largely resolved the blood-filled lymphatics in Chd4 mutants. Urokinase reduction also ameliorated liver hemorrhage and prolonged embryonic survival by reducing plasmin-mediated extracellular matrix degradation around sinusoidal blood vessels. These results highlight the susceptibility of LV thrombi and liver sinusoidal vessels to plasmin-mediated damage and demonstrate the importance of CHD4 in regulating embryonic plasmin activation after mid-gestation.

SUBMITTER: Crosswhite PL 

PROVIDER: S-EPMC4887170 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

CHD4-regulated plasmin activation impacts lymphovenous hemostasis and hepatic vascular integrity.

Crosswhite Patrick L PL   Podsiadlowska Joanna J JJ   Curtis Carol D CD   Gao Siqi S   Xia Lijun L   Srinivasan R Sathish RS   Griffin Courtney T CT  

The Journal of clinical investigation 20160503 6


The chromatin-remodeling enzyme CHD4 maintains vascular integrity at mid-gestation; however, it is unknown whether this enzyme contributes to later blood vessel or lymphatic vessel development. Here, we addressed this issue in mice harboring a deletion of Chd4 specifically in cells that express lymphatic vessel endothelial hyaluronan receptor 1 (LYVE1), which include lymphatic endothelial cells (LECs) and liver sinusoidal endothelial cells. Chd4 mutant embryos died before birth and exhibited sev  ...[more]

Similar Datasets

| S-EPMC6204085 | biostudies-literature
| S-EPMC3861115 | biostudies-literature
| S-EPMC6857586 | biostudies-literature
| S-EPMC4000726 | biostudies-literature
| S-EPMC3302445 | biostudies-literature
| S-EPMC3715430 | biostudies-literature
| S-EPMC4386736 | biostudies-literature
| S-EPMC1606492 | biostudies-literature
| S-EPMC3362071 | biostudies-literature
| S-EPMC3173128 | biostudies-literature